Ocular neovascularization: An epidemiologic review

Survey of Ophthalmology

Volumn 43, Issue 3, 1998, Pages 245-269

  Lee, Patricia ^a   Wang, Cindy C ^a   Adamis, Anthony P ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Age related macular degeneration; Angiogenesis; Diabetic retinopathy; Epidemiology

Indexed keywords

HEMOGLOBIN; INSULIN;

ANGIOGENESIS; ANGIOGRAPHY; CENTRAL RETINA VEIN OCCLUSION; CHEMICAL BURN; CLINICAL TRIAL; CONTACT LENS; CORNEA NEOVASCULARIZATION; DIABETIC RETINOPATHY; EYE DISEASE; EYE INFECTION; HUMAN; INCIDENCE; IRIS DISEASE; LASER COAGULATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETROLENTAL FIBROPLASIA; REVIEW; RISK FACTOR; SICKLE CELL ANEMIA; SUBRETINAL NEOVASCULARIZATION;

CHOROID; CORNEAL NEOVASCULARIZATION; EYE; EYE DISEASES; HUMANS; INCIDENCE; IRIS; NEOVASCULARIZATION, PATHOLOGIC; PREVALENCE; RETINAL NEOVASCULARIZATION; UNITED STATES;

EID: 0031766152     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(98)00035-6     Document Type: Review

References (165)

1. Adamis A.P., Schein O.D. Chlamydia and Acanthamoeba infections of the eye. Jakobiec F.A., Albert D.M. Principles and Practice of Ophthalmology. 1994;179-190 WB Saunders, Philadelphia.
2. Aiello L.P. Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol. 8:1997;19-31.
3. Aiello L.P., Cavallerano J., Bursell S. Diabetic eye disease. Endocrinol Metab Clin North Am. 25:1996;271-291.
4. Amano S., Rohan R., Kuroki M., Tolentino M., Adamis A.P. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 39:1998;18-22.
5. Anderson D.M., Morin J.D., Hunter W.S. Rubeosis iridis. Can J Ophthalmol. 6:1971;183-188.
6. Archambault P., Gomolin J.E.S. Incidence of retinopathy of prematurity among infants weighing 2000 g or less at birth. Can J Ophthalmol. 22:1987;218-220.
7. Belin M.W., Catalano R.A., Scott J.L. Burns of the eye. Catalano R.A. Ocular Emergencies. 1992;179-190 WB Saunders, Philadelphia.
8. Binder P.S. Myopic extended wear with Hydrocurve II soft contact lens. Ophthalmology. 90:1983;623-626.
9. Bird A.C., Bressler N.M., Bressler S.B.et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 39:1995;367-374.
10. National Society to Prevent Blindness: Vision Problems in the US. Data Analysis, Definitions, Data Sources, Detailed Data Tables, Analyses, Interpretation. New York, National Society to Prevent Blindness, 1980.
11. Bossi E., Koerner F. Retinopathy of prematurity. Intens Care Med. 21:1995;241-246.
12. Bossi E., Koerner F., Flurty B., Zulauf M. Retinopathy of prematurity. a risk factor analysis with univariate and multivariate statistics Helv Paediatr Acta. 39:1984;307-317.
13. Bressler N.M., Bressler S.B., West S.K., Fine S.L., Taylor H.R. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol. 107:1989;847-852.
14. Bressler N.M., Munoz B., Maguire M.G.et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Arch Ophthalmol. 113:1995;301-308.
15. Bressler S.B., Maguire M.G., Bressler N.M., Fine S.L. The Macular Photocoagulation Study Group. relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration Arch Ophthalmol. 108:1990;1442-1447.
16. Brodell L.P., Olk R.J., Arribas N.P.et al. Neovascular glaucoma. a retrospective analysis of treatment with peripheral panretinal cryotherapy Ophthalmic Surg. 18:1987;200-206.
17. Brown G.C., Magargal L.E., Schachat A., Shah H. Neovascular glaucoma. Etiologic considerations. Ophthalmology. 91:1984;315-320.
18. Chandra A. Health aspects of pregnancy and childbirth. United States, 1982-88 Vital Health Stat. 18:1995;50.
19. Chandra S.R., Gragoudas E.S., Friedman E., Van Buskirk E.M., Klein M.L. Natural history of disciform degeneration of the macula. Am J Ophthalmol. 78:1974;579-582.
20. Charache S. Eye disease in sickling disorders. Hematol Oncol Clin North Am. 10:1996;1357-1362.
21. Cohen S.Y., Laroche A., Leguen Y., Soubrane G., Coscas G.J. Etiology of choroidal neovascularization in young patients. Ophthalmology. 103:1996;1241-1244.
22. Colby K.A., Adamis A.P. Prevalence of corneal neovascularization in a general eye service population (abstract). Invest Ophthalmol Vis Sci. 37(Suppl):1996;S593.
23. Committee for the Classification of Retinopathy of Prematurity: An international classification of retinopathy of prematurity. Arch Ophthalmol 102:1130-1134, 1984.
24. Condon P.I., Serjeant G.R. Ocular findings in elderly cases of homozygous sickle-cell disease in Jamaica. Br J Ophthalmol. 60:1976;361-364.
25. Condon P.I., Serjeant G.R. Behaviour of untreated proliferative sickle retinopathy. Br J Ophthalmol. 64:1980;404-411.
26. Cruickshanks K.J., Klein R., Klein B.E.K. Sunlight and age-related macular degeneration. the Beaver Dam eye study Arch Ophthalmol. 111:1993;514-518.
27. David R., Zangwill L., Badarna M., Yassur Y. Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica. 197:1988;69-74.
28. Delaney W.V. Jr., Oates R.P. Senile macular degeneration. preliminary study Ann Ophthalmol. 14:1982;21-24.
29. Denekamp J. Vasculature as a target for tumor therapy. Hammerson F., Hudlicka O. Progress in Applied Microcirculation. 1984;Karger, Basel.
30. Diabetes Control and Complications Trial Research Group The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol. 113:1995;36-51.
31. Diabetic Retinopathy Study Research Group Photocoagulation treatment of proliferative diabetic retinopathy. the second report of diabetic retinopathy study findings Ophthalmology. 85:1978;82-106.
32. Diabetic Retinopathy Study Research Group Four risk factors for severe visual loss in diabetic retinopathy. The third report from the DRS. Arch Ophthalmol. 97:1979;654-655.
33. Diabetic Retinopathy Study Research Group Diabetic Retinopathy Study, report 6. Design, methods, and baseline results Invest Ophthalmol Vis Sci. 21:1981;149-209.
34. Diabetic Retinopathy Study Research Group Photocoagulation treatment of proliferative diabetic retinopathy. clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8 Ophthalmology. 88:1981;583-600.
35. Early Treatment Diabetic Retinopathy Study Research Group: Early photocoagulation for diabetic retinopathy. ETDRS report No. 9. Ophthalmology 98:766-785, 1991.
36. Efron N. Vascular response of the cornea to contact lens wear. J Am Optom Assoc. 58:1987;836-846.
37. Eye Disease Case-Control Study Group Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 110:1992;1701-1708.
38. Eye Disease Case-Control Study Group Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 111:1993;104-109.
39. Ferris F. Early photocoagulation in patients with either type I or type II diabetes. Trans Am Ophthalmol Soc. 94:1996;505-537.
40. Folberg R., Rummelt V., Parys-Van Ginderdeuren R.et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 100:1993;1389-1398.
41. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 267:1992;10931-10934.
42. Fox P.D., Dunn D.T., Morris J.S., Serjeant G.R. Risk factors for proliferative retinopathy. Br J Ophthalmol. 74:1990;172-176.
43. Freund K.B., Yannuzzi L.A., Sorenson J.A. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol. 115:1993;786-791.
44. Gartner S., Henkind P. Neovascularization of the iris (rubeosis iridis). Surv Ophthalmol. 22:1978;291-312.
45. Gass J.D.M. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 90:1973;206-217.
46. Gass J.D.M. Radial chorioretinal folds. a sign of choroidal neovascularization Arch Ophthalmol. 99:1981;1016-1018.
47. Gass J.D.M. Serous retinal pigment epithelial detachment with a notch. a sign of occult choroidal neovascularization Retina. 4:1984;205-220.
48. Gibson J.M., Rosenthal A.R., Lavery J. A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc U K. 104:1985;196-203.
49. Goldberg J., Flowerdew G., Smith E., Brody J.A., Tso M.O.M. Factors associated with age-related macular degeneration. an analysis of data from the first National Health and Nutrition Examination Survey Am J Epidemiol. 128:1988;700-710.
50. Goldberg M.F. Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol. 71:1971;649-665.
51. Goldberg M.F. Natural history of untreated proliferative sickle retinopathy. Arch Ophthalmol. 85:1971;428-437.
52. Green W.R. The uveal tract. Spencer W.H. Ophthalmic Pathology. An Atlas and Textbook:1986;1513-1521 WB Saunders, Philadelphia.
53. Green W.R., Wilson D.J. Choroidal neovascularization. Ophthalmology. 93:1986;1169-1176.
54. Gregor Z., Bird A.C., Chisholm I.H. Senile disciform macular degeneration in the second eye. Br J Ophthalmol. 61:1977;141-147.
55. Gregor Z., Joffe L. Senile macular changes in the black African. Br J Ophthalmol. 62:1978;547-550.
56. Haffner S.M., Fong D., Stern M.P.et al. Diabetic retinopathy in Mexican-Americans and non-Hispanic whites. Diabetes. 37:1988;878-884.
57. Hayreh S.S. Classification of central retinal vein occlusion. Ophthalmology. 90:1983;458-474.
58. Hayreh S.S., Rojas P., Podhajsky P., Montague P., Woolson R.F. Ocular neovascularization with retinal vascular occlusion. III. Ophthalmology. 90:1983;488-506.
59. Henkind P. Ocular neovascularization. The Krill memorial lecture. Am J Ophthalmol. 85:1978;287-301.
60. Higgins R.A. Neovascular glaucoma associated with ocular hypoperfusion secondary to carotid artery disease. Aust J Ophthalmol. 12:1984;155-162.
61. Holz F.G., Wolfensberger T.J., Piguet B. Bilateral macular drusen in age-related macular degeneration. Ophthalmology. 101:1994;1522-1528.
62. Hoskins H.D. Neovascular glaucoma. current concepts Trans Am Acad Ophthalmol Otolaryngol. 78:1974;330-333.
63. Huang A.J.W., Watson B.D., Hernandez E., Tseng S.C.G. Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization. Ophthalmology. 95:1988;228-235.
64. Hyman L.G., Lilienfeld A.M., Ferris F.L., Fine S.L. Senile macular degeneration. a case-control study Am J Epidemiol. 118:1983;213-227.
65. Imesch P.D., Bindley C.D., Wallow I.H.L. Clinicopathologic correlation of intraretinal microvascular abnormalities. Retina. 17:1997;321-329.
66. International Committee for the Classification of Late Stages of Retinopathy of Prematurity: An international classification of retinopathy of prematurity. II. The classification of retinal detachment. Arch Ophthalmol 105:906-912, 1987.
67. Javitt J.C., Aiello L.P., Bassi L.J., Chiang Y.P., Canner J.K. Detecting and treating retinopathy in patients with type I diabetes mellitus. Ophthalmology. 98:1991;1565-1574.
68. Javitt J.C., Aiello L.P., Chiang Y.et al. Preventive eye care in people with diabetes is cost-saving to the federal government. Diabetes Care. 17:1994;909-917.
69. Jonasson F., Thordarson K. Prevalence of ocular disease and blindness in a rural area in the eastern region of Iceland during 1980 through 1984. Acta Ophthalmol Suppl. 182:1987;40-43.
70. Kahn H.A., Leibowitz H.M., Ganley J.P.et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 106:1977;33-41.
71. Kalina R.E., Karr D.J. Retrolental fibroplasia. Experience over two decades in one institution. Ophthalmology. 89:1982;91-95.
72. Kamiya C. Cosmetic extended wear of oxygen permeable hard contact lenses. one year follow-up J Am Optom Assoc. 57:1986;182-184.
73. Keenan J.M., Dodson P.M., Kritzinger E.E. Are there medical conditions specifically underlying the development of rubeosis in central retinal vein occlusion? Eye. 7:1993;407-410.
74. Keith C.G., Doyle L.W., Kitchen W.H., Murton L.J. Retinopathy of prematurity in infants of 24-30 weeks' gestational age. Med J Aust. 150:1989;293-296.
75. Kimmel A.S., Magargal L.E., Annesley W.H., Donoso L.A. Diabetic retinopathy under age 20. A review of 71 cases. Ophthalmology. 92:1985;1047-1050.
76. Klein B.E.K., Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 100:1982;571-573.
77. Klein B.E.K., Moss S.E., Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 13:1990;34-40.
78. Klein HA, Moorehead HB: Statistics on Blindness in the Model Reporting Area, 1969-1970. (DHEW Publication No. [NIH] 73-427, 1970). Bethesda, US Dept of Health, Education & Welfare, 1973.
79. Klein R. Retinopathy in a population-based study. Trans Am Ophthalmol Soc. 90:1992;561-594.
80. Klein R, Klein BEK: Vision disorders in diabetes, in Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH (eds): National Diabetes Data Group: Diabetes in America. (NIH Publication No. 95-1468), Bethesda, National Institute of Diabetes and Digestive and Kidney Diseases, 1995, ed 2, pp 293-338.
81. Klein R., Klein B.E.K., Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. the Beaver Dam Eye Study Ophthalmology. 100:1993;406-414.
82. Klein R., Klein B.E.K., Jensen S.C., Meuer S.M. The five-year incidence and progression of age-related maculopathy. Ophthalmology. 104:1997;7-21.
83. Klein R., Klein B.E.K., Linton K.L.P. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 99:1992;933-943.
84. Klein R., Klein B.E.K., Linton K.L.P., DeMets D.L. The Beaver Dam Eye Study. the relationship of age-related maculopathy to smoking Am J Epidemiol. 137:1993;190-200.
85. Klein R., Klein B.E.K., Moss S.E. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 15:1992;1875-1891.
86. Klein R., Klein B.E.K., Moss S.E., Cruickshanks K.J.C. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 112:1994;1217-1228.
87. Klein R., Klein B.E.K., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 102:1984;527-532.
88. Klein R., Klein B.E.K., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 102:1984;520-526.
89. Klein R., Palta M., Allen C.et al. Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes. Arch Ophthalmol. 115:1997;351-356.
90. Klein R., Rowland M.L., Harris M.I. Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey Ophthalmology. 102:1995;371-381.
91. Klintworth G.K. Corneal Angiogenesis. A Comprehensive Critical Review. 1991;Springer-Verlag, New York.
92. Kostraba J.N., Klein R., Dorman J.S.et al. The Epidemiology of Diabetes Complications Study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol. 133:1991;381-391.
93. Laatikainen L. Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma. Br J Ophthalmol. 61:1977;278-284.
94. Laatikainen L. A prospective follow-up study of panretinal photocoagulation in preventing neovascular glaucoma following ischaemic central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 220:1983;236-239.
95. Laatikainen L., Larinkari J., Teramo K., Raivio K.O. Occurrence and prognostic significance of retinopathy in diabetic pregnancy. Metabol Pediatr Ophthalmol. 4:1980;191-195.
96. Lamer L. Extended-wear contact lenses for myopes. A follow-up study of 400 cases. Ophthalmology. 90:1983;156-161.
97. Leibowitz H.M., Krueger D.E., Maunder L.R.et al. The Framingham Eye Study monograph. An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975 Surv Ophthalmol. 24(Suppl):1980;335-610.
98. Levy B. Rigid gas-permeable lenses for extended wear. a 1-year clinical evaluation Am J Optom Physiol Opt. 62:1985;889-894.
99. Macular Photocoagulation Study Group Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol. 108:1990;825-831.
100. Macular Photocoagulation Study Group Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol. 111:1993;1189-1199.
101. Macular Photocoagulation Study Group Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol. 115:1997;714-747.
102. Madsen P.H. Rubeosis of the iris and haemorrhagic glaucoma in patients with proliferative diabetic retinopathy. Br J Ophthalmol. 55:1971;368-371.
103. Magargal L.E., Brown G.C., Augsburger J.J., Donoso L.A. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology. 89:1982;780-784.
104. Magargal L.E., Brown G.C., Augsburger J.J., Parrish R.K. Neovascular glaucoma following central retinal vein obstruction. Ophthalmology. 88:1981;1095-1101.
105. Maltzman B., Mulvihill M.N., Greenbaum A. Senile macular degeneration and risk factors. a case-control study Ann Ophthalmol. 11:1979;1197-1201.
106. Manire G.P. Biological characteristics of Chlamydiae. Hobson D., Homes K.K. Nongonococcal Urethritis and Related Infection. 1977;167-175 American Society for Microbiology, Washington, DC.
107. Martinez G.S., Campbell A.J., Reinken J., Allan B.C. Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol. 94:1982;181-189.
108. Miller J.W., D'Amico D.J. Proliferative diabetic retinopathy. Jakobiec F.A., Albert D.M. Principles and Practice of Ophthalmology. 1994;760-782 WB Saunders, Philadelphia.
109. Nelson R.G., Wolder J.A., Horton M.B.et al. Proliferative retinopathy in NIDDM. incidence and risk factors in Pima Indians Diabetes. 38:1989;435-440.
110. Newsome D.A., Swartz M., Leone N.C., Elson R.C., Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 106:1988;192-198.
111. Ng Y.K., Fielder A.R., Shaw D.E., Levene M.I. Epidemiology of retinopathy of prematurity. Lancet. 2:1988;1235-1238.
112. Ohrt V. The frequency of rubeosis iridis in diabetic patients. Acta Ophthalmol. 49:1971;301-307.
113. Palmer E.A., Flynn J.T., Hardy R.J.et al. Incidence and early course of retinopathy of prematurity. Ophthalmology. 98:1991;1628-1640.
114. Purohit D.M., Ellison C., Zierler S., Miettinen O.S., Nadas A. Risk factors for retrolental fibroplasia. experience with 3025 premature infants Pediatrics. 76:1985;339-344.
115. Quinlan P.M., Elman M.J., Bhatt A.K., Mardesich P., Enger C. The natural course of central retinal vein occlusion. Am J Ophthalmol. 110:1990;118-123.
116. Rand L.I., Krolewski A.S., Aiello L.M.et al. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med. 313:1985;1433-1438.
117. Rehak J. Rubeosis iridis and neovascular glaucoma. I. Etiopathogenesis and treatment - the present state of the problem. Acta Univ Palack Olomuc Fac Med. 134:1992;101-103.
118. Reisner S.H., Amir I., Shohat M.et al. Retinopathy of prematurity. incidence and treatment Arch Dis Child. 60:1985;698-701.
119. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
120. Risau W., Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 11:1995;73-91.
121. Rodman H.M., Singerman U., Aiello L.M., Merkatz I.R. Diabetic retinopathy and its relationship to pregnancy. Merkatz I.R., Adam P.A.J. The Diabetic Pregnancy. A Perinatal Perspective:1979;73-91 Grune and Stratton, New York.
122. Rosenn B., Miodovnik M., Kranias G.et al. Progression of diabetic retinopathy in pregnancy. association with hypertension in pregnancy Am I Obstet Gynecol. 166:1992;1214-1218.
123. Roth H.W. The etiology of ocular irritation in soft lens wearers. distribution in a large clinical sample Contact Intraocul Lens Med J. 4:1978;38-47.
124. Rummelt V., Folberg R., Woolson R.F., Hwang T., Pe'er J. Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas. Ophthalmology. 102:1995;844-851.
125. Ryan S.J. Subretinal neovascularization. Ryan S.J. Retina. 1989;107-125 CV Mosby, St Louis.
126. Saigal S., O'Brodorovich H. Long-term outcome of preterm infants with respiratory disease. Clin Perinatol. 14:1987;635-650.
127. Schatz H. The senile maculopathies and the retinal pigment epithelium. Int Ophthalmol Clin. 15:1975;169-180.
128. Schecter D.R., Emery J.M., Soper J.W. Corneal vascularization in therapeutic soft-lens wear. Contact Intraocul Lens Med J. 1:1975;141-145.
129. Schein O.D., Glynn R.J., Poggio E.C.et al. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med. 321:1989;773-778.
130. Schultze R.R. Rubeosis iridis. Am J Ophthalmol. 63:1967;487-495.
131. Seddon J.M., Ajani U.A., Sperduto R.D.et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 272:1994;1413-1420.
132. Shields C.L., Shields J.A., Baez K., Cater J.R., De Potter P. Optic nerve invasion of retinoblastoma. Cancer. 73:1994;692-698.
133. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
134. Sinclair S.H., Aaberg T.M., Meredith T.A. A pars plana filtering procedure combined with lensectomy and vitrectomy for neovascular glaucoma. Am J Ophthalmol. 93:1982;185-191.
135. Sinclair S.H., Gragoudas E.S. Prognosis for rubeosis iridis following central retinal vein occlusion. Br J Ophthalmol. 63:1979;735-743.
136. Sommer A., Tielsch J.M., Katz J.et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 325:1991;1412-1417.
137. Sperduto R.D., Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol. 104:1986;216-219.
138. Spoor T.C., Hartel W.C., Wynn P., Spoor D.K. Complications of continuous-wear soft contact lenses in a nonreferral population. Arch Ophthalmol. 102:1984;1312-1313.
139. Stark W.J., Martin N.F. Extended-wear contact lenses for myopic correction. Arch Ophthalmol. 99:1981;1963-1966.
140. Strahlman E.R., Fine S.L., Hillis A. The second eye of patients with senile macular degeneration. Arch Ophthalmol. 101:1983;1191-1193.
141. Tabbara K.F., Ross-Degnan D. Blindness in Saudi Arabia. JAMA. 255:1986;3378-3384.
142. Talbot J.F., Bird A.C., Serjeant G.R., Hayes R.J. Sickle cell retinopathy in young children in Jamaica. Br J Ophthalmol. 66:1982;149-154.
143. Tamboli A., Podgor M.J., Horm J.W. The incidence of retinoblastoma in the United States. 1974 through 1985 Arch Ophthalmol. 108:1990;128-132.
144. Tasman W., Magargal L.E., Augsburger J.J. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology. 87:1980;400-402.
145. Taylor H.R., Dax E.M. Ocular onchocerciasis. Tabbara K.F., Hyndiuk R.A. Infections of the Eye. 1996;673-683 Little, Brown and Co, Boston.
146. Teeters V.M., Bird A.C. The development of neovascularization in senile disciform macular degeneration. Am J Ophthalmol. 76:1973;1-18.
147. Tielsch JA: Vision Problems in the United States: A Report on Blindness and Vision Impairment in Adults Age 40 and Older: Prevent Blindness America. Schaumburg, Prevent Blindness, Inc, 1995, pp 1-20.
148. Tolentino M.J., Miller J.W., Gragoudas E.S.et al. Intravitreal injections of vascular endothelial growth factor produce retinal isehemia and microangiopathy in an adult primate. Ophthalmology. 103:1996;1820-1828.
149. United States Bureau of the Census Statistical Abstract of the United States. 1996:1996;United States Bureau of the Census, Washington, DC.
150. Valentine P.J., Jackson J.C., Kalina R.E., Woodrum D.E. Increased survival of low birth weight infants. impact on the incidence of retinopathy of prematurity Pediatrics. 84:1989;442-445.
151. Vannas S. Glaucoma due to thrombosis of the central vein of the retina. Ophthalmologica. 142:1961;266-282.
152. Verdier D.D., Krachmer J.H. Clinical manifestations of herpes simplex virus infection of the eye. Blodi F.C. Herpes Simplex Infections of the Eye. 1984;1-27 Churchill Livingstone, New York.
153. Vinding T. Age-related macular degeneration. macular changes, prevalence and sex ratio: an epidemiological study of 1000 aged individuals Acta Ophthalmol. 67:1989;609-616.
154. Vingerling J.R., Dielemans I., Hofman A.et al. The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology. 102:1995;205-210.
155. Vingerling J.R., Klaver C.C.W., Hofman A., de Jong P.T.V.M. Epidemiology of age-related maculopathy. Epidemiol Rev. 17:1995;347-360.
156. Vitale S., Maguire M.G., Murphy R.P.et al. Interval between onset of mild nonproliferative and proliferative retinopathy in type I diabetes. Arch Ophthalmol. 115:1997;194-198.
157. Walton D.S., Grant W.M. Retinoblastoma and iris neovascularization. Am J Ophthalmol. 65:1968;598-599.
158. Wand M. Neovascular glaucoma. Jakobiec F.A., Albert D.M. Principles and Practice of Ophthalmology, 3. 1994;1485-1510 WB Saunders, Philadelphia.
159. Weinberg D.V., Seddon J.M. Venous occlusive diseases of the retina. Jakobiec F.A., Albert D.M. Principles and Practice of Ophthalmology, 2. 1994;735-746 WB Saunders, Philadelphia.
160. Weiss D.I. Vascular insufficiency (neovascular) glaucoma. An integrating pathogenetic concept Trans Ophthalmol Soc U K. 97:1977;280-287.
161. Wintrobe M.M., Lee G.R., Boggs D.R.et al. Clinical Hematology. 1981;Lea and Febiger, Philadelphia.
162. World Health Organization: Methodology for trachoma control. WHO Tech Rep Ser 703, 1970.
163. Yamaguchi R., Sunao U., Wakikawa E.et al. Evaluation of incidence and treatment of retinopathy of prematurity in Kurashiki Central Hospital in the past ten years. Folia Ophthalmol Jpn. 36:1985;1868-1875.
164. Yu V.Y.H., Lim C.T., Downe L.M. A 12-year experience of retinopathy of prematurity in infants 28 weeks gestation or < 1000 g birthweight. J Paediatr Child Health. 26:1990;205-208.
165. Zhang C.F., Zhu X.H., Dong F.T.et al. A clinical study on diabetic retinopathy. Chin Med J. 105:1992;234-236.